Ovarian Cancer Doctors in Turkey — Page 2

The doctor is an ECFMG and ESMO-certified medical and breast oncologist with over 20 years of experience, specializing in solid cancer, breast cancer, colorectal, and lung cancer treatment. Since 2016, the doctor has been a medical oncology specialist at Anadolu Medical Center.

The doctor graduated from Gülhane Military Medical Academy with a degree in general medicine and completed specialties in internal and medical oncology. The doctor has been a professor and associate professor at Gülhane Military Medical Academy, contributing significantly to medical education.

With over 110 papers on cancer management, the doctor is a member of several prestigious oncology organizations.

Professor Mustafa Özdoğan is a senior oncologist who has performed over 1,100 procedures and currently heads the Medical Oncology Department at Memorial Antalya Hospital.

• Holds specialist qualifications in both internal medicine and medical oncology
• Active member of the American Society of Clinical Oncology (ASCO)
• Recognised by the European Society for Medical Oncology (ESMO)
• Has published more than 40 research articles on cancer treatment protocols
• Leads a multidisciplinary oncology team at a major JCI-accredited hospital centre

The doctor is a seasoned gynecologist and obstetrician with a career spanning over two decades. After completing medical education at Istanbul University Istanbul Medical School in 1995, the doctor specialized in Gynecology and Obstetrics at Istanbul University Cerrahpaşa Medical School in 2002. The doctor has been serving at Anadolu Medical Center since 2005, focusing on gynecology, obstetrics, and urogynecology. The doctor is a member of several professional societies, including the Turkish Gynecology and Obstetrics Society and the AAGL, Advancing Minimally Invasive Gynecology Worldwide.

Professor Sadi Kerem Okutur is an award-winning medical oncologist at Memorial Bahçelievler Hospital who received the Oncology Research Award from the Turkish Medical Oncology Society.

• Specialises in chemotherapy and targeted drug protocols for ovarian cancer cases
• Active member of the European Society for Medical Oncology (ESMO)
• Published over 20 research papers and 10 book chapters on oncology care
• Expert in immuno-oncology, focusing on how the immune system fights tumours
• Coordinates complex treatment plans at a leading JCI-accredited hospital in Istanbul

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

The doctor graduated from Ankara University Medical School and completed residency training in internal medicine at Ankara GATA Medical School. Specializing in medical oncology and hematology, the doctor completed a clinical fellowship in the USA. A pioneer in Turkey, the doctor was part of the team that performed the first bone marrow transplantation in the country. The doctor has served as a visiting lecturer at prestigious institutions in London and Switzerland. Holding the European Medical Oncology Certificate, the doctor is a founding member of both The Turkish Society of Medical Oncology and the Turkish Oncology Group. The clinical focus includes breast, gastrointestinal, lung cancers, lymphomas, and myeloma.

Professor Sezer Saglam is a senior medical oncologist at Istanbul Florence Nightingale Hospital with high-level expertise in complex tumour management.

• Holds a professorship in medical oncology from Istanbul University
• Specialises in systemic therapies for advanced-stage gynaecological cancers
• Current member of the American Society of Clinical Oncology (ASCO)
• Member of the European Society for Medical Oncology (ESMO)
• Trained at the Istanbul University Oncology Institute

Professor Saban Sec leads the medical oncology team at Valued Med Hub Hospitals, focusing on urogenital and rare tumours. He serves as a representative for the Turkish Medical Oncology Association, helping set national standards for patient care.

• Specialises in urogenital cancers, managing complex malignancies of the reproductive system
• Expert in rare tumour treatments, providing options for hard-to-treat cases
• Researches genetic markers and mutation profiles to tailor specific drug therapies
• Member of the Turkish Medical Oncology Association and Istanbul Medical Chamber

Professor Ozcan Yildiz is a leading medical oncologist at Medipol Mega University Hospital with a deep academic background in treating complex gynaecological cancers.

• Specialises in managing dysgerminoma and gestational choriocarcinoma using targeted medical protocols
• Expert in treating metastatic neuroectodermal ovarian tumours, particularly in high-risk obstetric cases
• Focuses on managing hormonal complications and hypoadrenalism during endometrial and ovarian cancer treatment
• Published extensive research on paraneoplastic syndromes to improve patient safety during chemotherapy

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Education & Expertise

• 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Düzce University, Internal Medicine Specialization
• 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
• 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
• 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
• 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
• 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
• 2020 to Present – Professor, Sakarya University Faculty of Medicine
• 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

• 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
• 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

• TTOD (Turkish Society of Medical Oncology)
• ASCO (American Society of Clinical Oncology)
• ESMO (European Society for Medical Oncology)

Professor Mustafa Serkan Alemdar is a medical oncology specialist at Medical Park Antalya with deep roots in university-level clinical research.

• Specialises in medical oncology for managing ovarian malignancies and complex solid tumours
• Trained at Akdeniz University – a prominent Turkish centre for medical research
• Provides systemic therapies including targeted treatments designed to attack specific cancer cells
• Focuses on evidence-based protocols to manage disease progression and improve patient outcomes
• Coordinates care within a multidisciplinary team at Medical Park's oncology department

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Associate Professor Nail Paksoy is a board-certified medical oncologist specialising in drug-resistant and advanced ovarian cancer cases at Medipol Bahçelievler University Hospital.

• ESMO board-certified specialist with expert knowledge in European cancer treatment protocols
• Specialises in carboplatin desensitisation – a technique that allows patients to safely continue vital chemotherapy despite allergic reactions
• Serves as a sub-investigator for international clinical trials, including the use of Olaparib for advanced ovarian cancer
• Researches hemogram parameters to better predict patient outcomes and survival in late-stage ovarian carcinoma

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Ercan Ozden is a medical oncology specialist at VM Medical Park Pendik Hospital with deep roots in Istanbul's top medical institutions.

• Specialises in medical oncology at Kocaeli University – a leading research and teaching hospital
• Trained in internal medicine at Istanbul University Cerrahpasa School of Medicine
• Focuses on systemic treatments for advanced-stage ovarian cancer cases
• Expertise includes targeted therapies and chemotherapy protocols

Professor Gul Alco is a leading radiation oncologist at Medipol Hospital who specialises in precise radiotherapy for gynaecological tumours.

• Holds a professorship at Istanbul Medipol University, training the next generation of cancer specialists
• Uses intensity-modulated radiation therapy to target cancer cells while protecting surrounding healthy organs
• Member of the Turkish Society for Radiation Oncology and the European Society for Therapeutic Radiology and Oncology
• Focuses on curative and palliative radiotherapy for advanced-stage cases

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.